CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Summit Therapeutics PLC - ADR Company Snapshot
Summit Therapeutics PLC operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Summit Therapeutics PLC with three other companies in this sector in the United States: Integrated Biopharma, Inc. (2019 sales of $49.98 million ), Quotient Ltd (2019 sales: $29.13 million of which 100% was commercial-stage diagnostics), and Palatin Technologies, Inc. (2019 sales of $60.30 million of which 100% was Licenses, Grants and Contracts).

Sales Analysis.
   
   
 
  Stock Performance Chart for Summit Therapeutics PLC - ADR
 
  Stock Data: Recent Stock Performance:
  Current Price (11/29/2019): 1.50
(Figures in U.S. Dollars)
1 Week -0.7%   13 Weeks -11.8%  
4 Weeks 12.2%   52 Weeks 15.4%  
 
Summit Therapeutics PLC - ADR Key Data:
  Ticker: SMMT Country: United States
  Exchanges: BSE Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 56,840,788
(Year Ending Jan 2020).
Employees: 61
  Currency: U.S. Dollars Market Cap: 48,148,427
  Fiscal Yr Ends: January Shares Outstanding: 32,098,952
  Share Type: Closely Held Shares: 2,003,320
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.